These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38261266)

  • 41. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
    Danilov SM; Tovsky SI; Schwartz DE; Dull RO
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis.
    Li J; Shi J; Xiao J; Tran L; Wang X; Zhu HJ
    Drug Metab Dispos; 2022 Mar; 50(3):243-248. PubMed ID: 34933885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene.
    Johnson KA; Barry E; Lambert D; Fitzgerald M; McNicholas F; Kirley A; Gill M; Bellgrove MA; Hawi Z
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):655-64. PubMed ID: 24350812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carboxylesterase 1 genes: systematic review and evaluation of existing genotyping procedures.
    Rasmussen HB; Madsen MB;
    Drug Metab Pers Ther; 2018 Mar; 33(1):3-14. PubMed ID: 29427553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.
    Saiz-Rodríguez M; Belmonte C; Caniego JL; Koller D; Zubiaur P; Bárcena E; Romero-Palacián D; Eugene AR; Ochoa D; Abad-Santos F
    Clin Ther; 2019 Jun; 41(6):1199-1212.e2. PubMed ID: 31128980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.
    Stage C; Dalhoff K; Rasmussen HB; Schow Guski L; Thomsen R; Bjerre D; Ferrero-Miliani L; Busk Madsen M; Jürgens G
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):54-61. PubMed ID: 30801959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An overview of the clinical pharmacology of enalapril.
    Davies RO; Gomez HJ; Irvin JD; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril.
    Zhu HJ; Appel DI; Johnson JA; Chavin KD; Markowitz JS
    Biochem Pharmacol; 2009 Apr; 77(7):1266-72. PubMed ID: 19185566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI; Jackson B; Cubela R; Larmour I; Arnolda L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing.
    Zhao B; Bie J; Wang J; Marqueen SA; Ghosh S
    Am J Physiol Cell Physiol; 2012 Aug; 303(4):C427-35. PubMed ID: 22700792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.
    Westerkamp AC; Pereira RR; Huitema VR; Kouwert EAM; Matic M; van Schaik RHN; Punt N; Schoevers RA; Touw DJ
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):35-38. PubMed ID: 37851403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine?
    Laizure SC; Parker RB
    Xenobiotica; 2020 Jan; 50(1):92-100. PubMed ID: 31601149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril.
    Brunner HR; Nussberger J; Waeber B
    Acta Cardiol; 1986; 41(5):341-50. PubMed ID: 3022510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition.
    Laizure SC; Hu ZY; Potter PM; Parker RB
    Xenobiotica; 2020 Mar; 50(3):245-251. PubMed ID: 31039046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
    Ji Q; Zhang C; Xu Q; Wang Z; Li X; Lv Q
    Br J Clin Pharmacol; 2021 May; 87(5):2247-2255. PubMed ID: 33179295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir.
    Zhang Q; Melchert PW; Markowitz JS
    Chem Biol Interact; 2022 Sep; 365():110097. PubMed ID: 35964681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
    Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
    Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants.
    Zhu HJ; Markowitz JS
    Drug Metab Dispos; 2009 Feb; 37(2):264-7. PubMed ID: 19022936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetics of dabigatran etexilate interindividual variability.
    Dimatteo C; D'Andrea G; Vecchione G; Paoletti O; Cappucci F; Tiscia GL; Buono M; Grandone E; Testa S; Margaglione M
    Thromb Res; 2016 Aug; 144():1-5. PubMed ID: 27261537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.